SciELO - Scientific Electronic Library Online

 
vol.37 número3Fármacos prometedores y potenciales para el tratamiento de COVID-19Azoles de antes y ahora: una revisión índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

ZYLBERSZTAJN, Brenda et al. Plasmatic concentracion of piperacillin/tazobactam in pediatric patients on ECMO support. Preliminary analysis. Rev. chil. infectol. [online]. 2020, vol.37, n.3, pp.216-218. ISSN 0716-1018.  http://dx.doi.org/10.4067/s0716-10182020000300216.

Background:

Pharmacokinetics and optimal dosing of piperacillin tazobactam (PT) have not been well studied in pediatric patients undergoing extracorporeal oxygenation membrane (ECMO).

Aim:

To describe piperacillin plasmatic concentration and evaluate achievement of pharmaccokinetic/pharmacodinamic objective in patients on ECMO support.

Method:

We report three pediatric patients admitted to the Pediatric Intensive Care Unit, treated with PT undergoing ECMO. Plasmatic concentrations of piperacillin were obtained in the middle of the dosing interval using high performance liquid chromatography.

Results:

Plasmatic concentrations were 51,7-14,1 and 6,5 μg/mL for patient A, B and C respectively. Only one patient reached adequate concentrations.

Conclusion:

These preliminary results suggest that availability of plasmatic concentrations of piperacillin could optimize the achievement of pharmacokinetic/pharmacodynamic objectives in pediatric patients on ECMO support.

Palabras clave : Extracorporeal oxygenation membrane; piperacillin tazobactam; pediatrics; pharmacokinetics.

        · resumen en Español     · texto en Español     · Español ( pdf )